A method for purification and viral inactivation of human placenta hemoglobin

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 34, Issue 2, 2006, Pages 175-188

  Li, Tao ^a   Yu, Rong ^a   Zhang, Hong Hui ^b   Wang, Hong ^b   Liang, Wei Guang ^b   Yang, Xiao Ming ^b   Yang, Cheng Min ^b  

^a SICHUAN UNIVERSITY   (China)

^b Institute of Tianjin Union Biotechnology Development   (China)

Author keywords

Heat treatment; Placenta hemoglobin; Purification; Viral inactivation

Indexed keywords

BLOOD; DRUG PRODUCTS; HEAT TREATMENT; OXYGEN; PHOSPHOLIPIDS; PROTEINS; PURIFICATION;

PLACENTA HEMOGLOBIN; PURIFIED PHB SOLUTION; VIRAL INACTIVATION;

HEMOGLOBIN;

HEMOGLOBIN; METHEMOGLOBIN; POLYMERIZED HEMOGLOBIN; REDUCING AGENT; STABILIZING AGENT;

ANALYTIC METHOD; ARTICLE; BLOOD TRANSFUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENATURATION; DEOXYGENATION; HEAT TREATMENT; HEMOLYSATE; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR WEIGHT; NONHUMAN; OXYGEN AFFINITY; PH; PLACENTA; PRECIPITATION; PURIFICATION; RAT; VIRUS INACTIVATION;

ANIMALS; EXCIPIENTS; FEMALE; HEAT; HEMOGLOBINS; HUMANS; HYDROGEN-ION CONCENTRATION; PLACENTA; RATS; REDUCING AGENTS; VIRUS INACTIVATION;

EID: 33645014543     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190600580231     Document Type: Article

References (23)

1. Chang, T.M.S. (2003). Artificial cells for replacement of metabolic organ functions. Artif Cells Blood Substit Immobil. Biotechnol. 31(2): 151-161.
2. Chang, T.M.S. (2002). Red blood cell substitutes. Artif Cells Blood Substit Immobil Biotechnol. 30(5&6): 421-437.
3. Yang, C.M., Li, J.Z., Ji, Y. (2001). Scientific Basis of Transfusion Medicine. University of Science and Technology of China Press: Beijing, pp. 547-568.
4. Schreiber, G.B., Busch, M.P., Kleinman, S.H., Korelitz, J.J. (1996). The risk of transfusion-transmitted viral infections. New Engl. J. Med. 334(26): 1685-1690.
5. Nelson, Deanna J. (2002). Blood substitutes: hemoglobin-based oxygen carriers. Encyclopedia of Pharmaceutical Technology 3: 236-262.
6. Gilmore, Thomas M. (2003). "Pasteurization systems," in Encyclopedia of Agricultural, Food, and Biological Engineering, Dennis R. Heldman, Ed., Marcel Dekker Inc., pp. 734-739.
7. Azari, M., Ebeling, A., Baker, R., Burhop, K., Camacho, T., Estep, T., Guzder, S., Marshall, T., Rohn, K., Sarajari, R. (1998). Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb™) for viral inactivation. Artif Cells Blood Substit Immobil. Biotechnol. 25: 577-582.
8. Azari, M., Catarello, J., Burhop, K., Camacho, T., Ebeling, A., Estep, T., Guzder, S., Krause, K., Marshall, T., Rohn, K., Sarajari, R. (1996). Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb™) for viral inactivation-effect of crosslinking. Artif Cells Blood Substit Immobil. Biotechnol. 24(4): 303.
9. Hens, Harry J.H., Grinwis, Marc, Fokke, G., Terpstra, Bakker, Joa C. (1996). Validation of virus inactivation by pasteurization of hemoglobin solutions. Artif Cells Blood Substit Immobil. Biotechnol. 24(4): 349.
10. Estep, T.N., Bechtel, M.K., Miller, T.J., Bagdasarian, A. (1988). Virus inactivation in hemoglobin solutions by heat. Blood Substit. 16(1-3): 129-134.
11. Sakai, H., Takeoka, S., Nishide, H., Tsuchida, E. (1994). Convenient method to purify hemoglobin. Artif Cells Blood Substit Immobil Biotechnol. 22(3): 651-656.
12. Chang, T.M.S. (1964). Semi-permeable microcapsules. Science 146: 524-525.
13. Chang, T.M.S. (1997). Blood Substitutes: Principle, Methods, Products and Clinical Trials, Karger Publisher: Basel, pp. 1-141.
14. Chang, T.M.S. (2000). Red blood cell substitutes. Best Pract. Res. Clin. Haematol. 13: 651-668.
15. Winslow, R.M. (2000). Blood substitutes. Advanced Drug Delivery Reviews 40: 131-142.
16. Sharma, A., Martin, M.J., Okabe, J.F., Truglio, R.A., Dhanjal, N.K., Logan, J.S., Khumar, R. (1994). An isologous porcine promoter permits high level expression of human hemoglobin in transgenic swine. Bio-Technology 12: 55-59.
17. Benesch, R., Benesch, R.E., Yung, S., Edalji, R. (1975). Hemoglobin covalently bridged across the polyphosphate binding site. Phys. Res. Commum. 63: 1123.
18. Drabkin, D. (1949). The standardization of hemoglobin measurement. Am. J. Med. Sci. 217: 710-711.
19. Evelyn, K.A., Malloy, H.T. (1938). Microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood. J. Biol. Chem. 126: 655-662.
20. Agnillo, F., Alayash, A.I. (2000). Site-specific modification and toxicity of blood substitutes, the case of diaspirin cross-linked hemoglobin. Advanced Drug Delivery Reviews 40: 199-212.
21. Bunn, H.F., Forget, B.G. (1986). Hemoglobin: Molecular, Genetic and Clinical Aspects, W.B. Saunders Co.: Philadelphia.
22. Strong, F.M., Koch, G.H. (1974). Biochemisty Laboratory Manual, WM.C. Borwn Co. Publishers: Lowa, USA, pp. 150-156.
23. Wang, H.Y., Zheng, W.J., Bu, F.R., Zhu, X.X., Ma, L.R. (2001). Researches on the manufacture of blood substitute's stroma polymerized bovine hemoglobin. Chin. Pharm. J. 36(6): 416-419.